Advancing IBD Management: A Literature Review on the Role of Non‐Invasive Blood‐Based Biomarkers in Predicting and Assessing Pharmacodynamic Response to Treatment

Documenti analoghi

• Population Pharmacokinetic and Pharmacodynamic Prediction for Tebipenem Pivoxil Treatment of Pediatric Shigellosis
  di: Cindy X. Zhang, et al.
  Pubblicazione: (2025)
• Evaluating miRNA Sequencing and Integrative Proteomics for Identifying Plasma miRNAs as Potential Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
  di: Mai Mehanna, et al.
  Pubblicazione: (2025)
• Glycoprotein Non‐Metastatic Melanoma Protein B ( GPNMB ): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635
  di: Geraldine Gontier, et al.
  Pubblicazione: (2026)
• Translational Pharmacokinetic‐Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI ‐6148 for the Treatment of Cutaneous Leishmaniasis
  di: Rasmus Hansen Henninger, et al.
  Pubblicazione: (2026)
• Pharmacodynamics of Aspirin Through Gestation: Predictors of Aspirin Response and Association With Pregnancy Outcome, a Prospective Cohort Study
  di: Rupsa C. Boelig, et al.
  Pubblicazione: (2025)